...
首页> 外文期刊>Integrative Medicine Research >Licorice ethanol extract improves symptoms of polycytic ovary syndrome in Letrozole-induced female rats
【24h】

Licorice ethanol extract improves symptoms of polycytic ovary syndrome in Letrozole-induced female rats

机译:甘草乙醇提取物改善来曲唑诱导的雌性大鼠多囊卵巢综合征的症状

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Licorice (Glycyrrhizae radix et rhizome, GRR) has long been used as an ingredient in Korean traditional medicinal herbal formulas for various metabolic and reproductive diseases. Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. In the present study, we examined the effects of GRR extract on PCOS-like symptoms in female rats. Methods Symptoms of PCOS were induced by Letrozole treatment for 4 weeks in 6-week-old female SD rats, after which the effects of GRR extract on recovery of normal hormonal levels and polycystic ovaries were assessed. Serum levels of luteinizing hormone (LH), follicular-stimulating hormone (FSH), LH/FSH ratio, and follicular cysts were evaluated, followed by the expression levels of known follicular phase markers such as Kitl , Cyp11a1 , and Ptgs2 . Results The serum level of FSH was reduced only in the Lestrozole treatment group (PCOS), whereas significant recovery of FSH level was observed in the Letrozole and GRR co-treatment group (PCOS + GRR). Serum LH levels were not altered in any of the groups. Furthermore, the LH/FSH ratio (known biomarker for PCOS) was elevated only in the Letrozole treatment group (PCOS), whereas it was significantly reduced in the Letrozole and GRR co-treatment group (PCOS + GRR). For histological changes, follicular cysts, antral follicles, and increased thickness of the theca- and granulosa layers were observed in the PCOS group, whereas these alterations were remarkably reversed by GRR treatment. Conclusion These results suggest that GRR extract inhibits the symptoms of PCOS by regulating imbalanced hormonal levels and irregular ovarian follicles.
机译:背景技术甘草(甘草,GRR)长期以来一直被用作韩国传统药用草药配方中用于各种代谢疾病和生殖疾病的成分。多囊卵巢综合征(PCOS)是绝经前女性的常见内分泌疾病。在本研究中,我们检查了GRR提取物对雌性大鼠PCOS样症状的影响。方法采用来曲唑治疗6周龄雌性SD大鼠4周,诱发PCOS症状,然后评价GRR提取物对正常激素水平和多囊卵巢恢复的影响。评估血清促黄体生成素(LH),促卵泡激素(FSH),LH / FSH比和卵泡囊肿的水平,然后评估已知卵泡相标志物(如Kit1,Cyp11a1和Ptgs2)的表达水平。结果仅在来曲唑治疗组(PCOS)中血清FSH水平降低,而在来曲唑和GRR联合治疗组(PCOS + GRR)中观察到FSH水平显着恢复。血清LH水平在所有组中均未改变。此外,LH / FSH比(PCOS的已知生物标志物)仅在来曲唑治疗组(PCOS)中升高,而在来曲唑和GRR联合治疗组(PCOS + GRR)中显着降低。对于组织学变化,在PCOS组中观察到了滤泡性囊肿,窦囊滤泡以及卵泡膜和颗粒层的厚度增加,而GRR治疗可明显逆转这些改变。结论这些结果表明,GRR提取物通过调节激素水平失调和卵巢卵泡不规则来抑制PCOS症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号